{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:16:33Z","timestamp":1779196593204,"version":"3.51.4"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:p>\n                    Hepatitis B virus (HBV) infection is not only a major cause of liver cirrhosis and hepatocellular carcinoma, but also contributes to a range of extrahepatic manifestations (EHMs) involving multiple organ systems. These EHMs may reflect underlying immune dysregulation and hepatic injury, yet their clinical characteristics and prognostic implications remain inadequately defined. This retrospective cohort study included 216 HBV-infected patients treated at our hospital between January 2022 and January 2023. Patients were divided into 2 groups based on the presence or absence of EHMs. Demographic data, biochemical profiles, liver function parameters, and immunological markers were collected. All patients were followed for 24 months. Chi-square test, Student\n                    <jats:italic toggle=\"yes\">t<\/jats:italic>\n                    test, and Cox proportional hazards regression models were used to evaluate the association between EHMs and adverse prognosis. In the EHM group (n\u2005=\u200588), the prevalence of hypertension and diabetes was significantly higher than in the non-EHM group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05), along with elevated blood glucose levels. The most commonly affected extrahepatic systems included the kidneys (32.9%), joints (23.9%), and skin (17.0%). Levels of alanine aminotransferase, aspartate aminotransferase, and total bilirubin were significantly higher in the EHM group, and the proportion of patients with Child-Pugh class C was also increased (26.1% vs 12.5%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.021). Immunological analysis showed elevated immunoglobulin G levels, decreased complement component 3 and complement component 4 levels, and a significantly higher rate of autoantibody positivity (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.008). During follow-up, the incidence of composite adverse outcomes was significantly higher in the EHM group (30.7% vs 15.6%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.012), and EHMs were identified as an independent risk factor for poor prognosis (HR\u2005=\u20052.14, 95% confidence interval: 1.17\u20133.91,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.014). Extrahepatic manifestations are common in patients with HBV infection and are associated with multi-system involvement, immune activation, impaired liver function, and increased risk of adverse outcomes. Early identification and management of EHMs may improve long-term prognosis in HBV-infected patients.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046510","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T17:00:10Z","timestamp":1769965210000},"page":"e46510","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective study on the clinical characteristics of extrahepatic manifestations in hepatitis B virus-infected patients and their association with prognosis"],"prefix":"10.1097","volume":"105","author":[{"given":"Le","family":"Zuo","sequence":"first","affiliation":[{"name":"Medical Laboratory Science, Yantian District People\u2019s Hospital, Shenzhen, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Biosafety and Quality Technology Department, Shenzhen Center for Disease Control and Prevention, Shenzhen, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Yantian District People\u2019s Hospital, Shenzhen, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9071-0179","authenticated-orcid":false,"given":"Peiyao","family":"Shi","sequence":"additional","affiliation":[{"name":"Medical Laboratory Science, Yantian District People\u2019s Hospital, Shenzhen, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.tim.2018.01.009","article-title":"Hepatitis B virus.","volume":"26","author":"Shih","year":"2018","journal-title":"Trends Microbiol"},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tim.2017.07.006","article-title":"Mechanisms of hepatitis B virus persistence.","volume":"26","author":"Tsai","year":"2018","journal-title":"Trends Microbiol"},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"a021402","DOI":"10.1101\/cshperspect.a021402","article-title":"Hepatitis B virus X and regulation of viral gene expression.","volume":"6","author":"Slagle","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jcmgh.2022.05.009","article-title":"HIRA in hepatitis B virus minichromosome regulation: another piece of the puzzle.","volume":"14","author":"Cheng","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/21691401.2018.1553786","article-title":"Gold nanoparticles and hepatitis B virus.","volume":"47","author":"Negahdari","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jinf.2021.07.021","article-title":"Extrahepatic manifestations related to hepatitis E virus infection and their triggering mechanisms.","volume":"83","author":"Wu","year":"2021","journal-title":"J Infect"},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"172","DOI":"10.14218\/JCTH.2018.00049","article-title":"HCV extrahepatic manifestations.","volume":"7","author":"Kuna","year":"2019","journal-title":"J Clin Transl Hepatol"},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.gtc.2019.10.002","article-title":"Extrahepatic manifestations of nonalcoholic fatty liver disease.","volume":"49","author":"Wattacheril","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"R9-20260519","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.3390\/v13112249","article-title":"A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy.","volume":"13","author":"Mazzaro","year":"2021","journal-title":"Viruses"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jceh.2022.02.004","article-title":"Extrahepatic manifestations in alcoholic liver disease.","volume":"12","author":"Nath","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/1744666X.2018.1538790","article-title":"Uncommon immune-mediated extrahepatic manifestations of HCV infection.","volume":"14","author":"Romano","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"R12-20260519","first-page":"3","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection.","volume":"3","author":"Cacoub","year":"2016","journal-title":"Ther Adv Infect Dis"},{"key":"R13-20260519","first-page":"95","article-title":"Extrahepatic manifestations of chronic HCV infection.","volume":"385","author":"Marvisi","year":"2021","journal-title":"N Engl J Med"},{"key":"R14-20260519","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jhep.2023.06.002","article-title":"Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.","volume":"79","author":"Ghany","year":"2023","journal-title":"J Hepatol"},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/liv.14176","article-title":"The impact of HBV flare on the outcome of HBV-related decompensated cirrhosis patients with bacterial infection.","volume":"39","author":"Cao","year":"2019","journal-title":"Liver Int"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/liv.13498","article-title":"Spectrum of hepatitis B and renal involvement.","volume":"38","author":"Shah","year":"2018","journal-title":"Liver Int"},{"key":"R17-20260519","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2147\/IDR.S437926","article-title":"Plasma thrombomodulin as a candidate biomarker for the diagnosis and prognosis of HBV-related acute-on-chronic liver failure.","volume":"17","author":"Zhou","year":"2024","journal-title":"Infect Drug Resist"},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"101128","DOI":"10.1016\/j.jhepr.2024.101128","article-title":"HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx.","volume":"6","author":"Ringelhan","year":"2024","journal-title":"JHEP Rep"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cld.2021.06.012","article-title":"Interpretation of HBV Serologies.","volume":"25","author":"Zamor","year":"2021","journal-title":"Clin Liver Dis"},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12985-021-01580-6","article-title":"Advances in HBV infection and replication systems in vitro.","volume":"18","author":"Xu","year":"2021","journal-title":"Virol J"},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/v13030368","article-title":"HBV-integration studies in the clinic: role in the natural history of infection.","volume":"13","author":"Pollicino","year":"2021","journal-title":"Viruses"},{"key":"R22-20260519","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3350\/cmh.2014.20.3.223","article-title":"Risk stratification of HBV infection in Asia-Pacific region.","volume":"20","author":"Kao","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"R23-20260519","doi-asserted-by":"crossref","first-page":"695384","DOI":"10.3389\/fmicb.2021.695384","article-title":"Hepadnaviral lymphotropism and its relevance to HBV persistence and pathogenesis.","volume":"12","author":"Coffin","year":"2021","journal-title":"Front Microbiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:02:16Z","timestamp":1779195736000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046510","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2025-07-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}